Osteoprotegerin levels are increased in serum of patients with multiple myeloma.

被引：0
|
作者：
Corso, A
Dovio, A
Sartori, ML
Rusconi, C
Klersy, C
Mangiacavalli, S
Zappasodi, P
Varettoni, M
Angeli, A
Lazzarino, M
机构：
[1] IRCCS Policlin San Matteo, Div Hematol, Pavia, Italy
[2] Univ Turin, Dipartimento Sci Clin & Biol, I-10124 Turin, Italy
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5196
引用
收藏
页码：367B / 367B
页数：1
相关论文
共 50 条
  • [41] Serum Hepcidin Levels in Multiple Myeloma
    Victor, Manolov
    Evgeniy, Hadjiev
    Gergana, Tzvetkova
    Julia, Petrova
    Vasil, Vasilev
    Borislav, Marinov
    Ivo, Bogov
    Zlatina, Gramatikova
    Kamen, Tzatchev
    CLINICAL LABORATORY, 2017, 63 (7-8) : 1273 - 1277
  • [42] Recovery of polyclonal immunoglobulin serum levels to normal levels after autologous stem cell transplantation predicts disease free survival in patients with multiple myeloma.
    Joao, C.
    Geyer, S.
    Markovic, S.
    Gertz, M.
    Lacy, M.
    Dispenzieri, A.
    Kumar, S.
    Hayman, S.
    Gastineau, D.
    Porrata, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 562S - 562S
  • [43] Retrospective analysis of second malignancies in patients with multiple myeloma.
    Talamo, Giampaolo
    Ehmann, W. Christopher
    Dolloff, Nathan G.
    Malysz, Jozef
    Drabick, Joseph J.
    Rybka, Witold B.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [44] The effect of zoledronic acid on serum osteoprotegerin in early stage multiple myeloma
    Martini, Giuseppe
    Gozzetti, Alessandro
    Gennari, Luigi
    Avanzati, Annalisa
    Nuti, Ranuccio
    Lauria, Francesco
    HAEMATOLOGICA, 2006, 91 (12) : 1720 - 1721
  • [45] Free light-chain measurement in serum compared with immunofixation of urine in patients with multiple myeloma.
    Nowrousian, MR
    Brandhorst, D
    Daniels, R
    Sammet, C
    Schuett, P
    Ebeling, P
    Buttkereit, U
    Opalka, B
    Flasshove, M
    Moritz, T
    Seeber, S
    BLOOD, 2003, 102 (11) : 367B - 367B
  • [46] Utility of bortezornib retreatment for patients with relapsed multiple myeloma.
    Wolf, Jeffrey Lee
    Richardson, Paul
    Schuster, Michael
    LeBlanc, Annette
    Battleman, David
    Walters, Ian
    BLOOD, 2006, 108 (11) : 1008A - 1008A
  • [47] Tracking dendritic cells in vivo in patients with multiple myeloma.
    Wall, DM
    Thompson, M
    Mileshkin, L
    Loveland, B
    Coverdale, J
    Xing, PX
    Bartholeyns, J
    Hicks, R
    Prince, M
    BLOOD, 2005, 106 (11) : 968A - 968A
  • [48] Initial studies of monocyte function in patients with multiple myeloma.
    Mainwaring, CJ
    Williams, M
    Singer, CRJ
    Smith, JG
    Prentice, AG
    Johnson, S
    Bell, A
    Kruger, A
    Gutteridge, C
    Mills, M
    Rhodes, E
    Kelsey, S
    BLOOD, 1995, 86 (10) : 3339 - 3339
  • [49] Bone mineral density (BMD) in patients with multiple myeloma.
    Hungria, VTM
    Gouveia, CHA
    Malvestiti, LF
    Bianco, AC
    Barros, JC
    Chiattone, CS
    Marone, MMS
    BLOOD, 1995, 86 (10) : 3328 - 3328
  • [50] Monocytic function is abnormal in some patients with multiple myeloma.
    Mainwaring, CJ
    Williams, MA
    Singer, CRJ
    Lush, RJ
    Smith, JG
    Prentice, AG
    Johnson, S
    Bell, A
    Kruger, A
    Gutteridge, C
    Mills, M
    Rhodes, E
    Kelsey, S
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 306 - 306
12345